General Prognostics (GPx)

General Prognostics (GPx) is a MedTech startup developing CardioID, a non-invasive, implant-free remote blood monitoring solution for heart failure patients. CardioID uses AI and machine learning to analyze data from wearable devices, providing predictive models more accurate than traditional implant-based methods. This expands access to continuous care for a broader patient population.

Buy Funded Startups lists

Funding Round:

Funding Amount:

Date: 12-Nov-2024

Investors: NEC X

Markets: MedTech, AI, Machine Learning, Healthcare, Biotechnology, Health Care, Information Technology, Medical, Medical Device

HQ: Boston, Massachusetts, United States

Founded: 2020

Website: https://www.gpx.ai/

LinkedIn: https://www.linkedin.com/company/gpx

Twitter: https://twitter.com/GPx_Boston

Instagram: